Livtencity 200 mg/1
MARIBAVIR · TABLET, COATED · Takeda Pharmaceuticals America, Inc.
No Recall History
Plain English
Livtencity is a tablet, coated containing maribavir at 200 mg/1, taken oral. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Livtencity
- Generic Name
- MARIBAVIR
- NDC Code (Product)
64764-800- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215596
- Drug Class
- Cytomegalovirus pUL97 Kinase Inhibitor [EPC]
- Marketing Start
- 11/23/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Livtencity used for?
Livtencity contains MARIBAVIR. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is Livtencity a controlled substance?
Livtencity is not classified as a controlled substance by the DEA.
What is the generic name for Livtencity?
The generic name for Livtencity is MARIBAVIR. There are no other listed brand versions of MARIBAVIR.
What is the NDC code for Livtencity 200 mg/1?
The NDC (National Drug Code) for Livtencity 200 mg/1 is 64764-800, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)